Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Operating Margin: 2010-2025

Historic Operating Margin for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to 7.86%.

  • OptimizeRx's Operating Margin rose 480400.0% to 7.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.17%, marking a year-over-year increase of 382000.0%. This contributed to the annual value of 14.88% for FY2024, which is 220400.0% up from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Operating Margin is 7.86%, which was up 480400.0% from 10.92% recorded in Q2 2025.
  • OptimizeRx's 5-year Operating Margin high stood at 11.25% for Q4 2024, and its period low was 54.32% during Q1 2023.
  • In the last 5 years, OptimizeRx's Operating Margin had a median value of 19.93% in 2024 and averaged 15.76%.
  • Its Operating Margin has fluctuated over the past 5 years, first plummeted by -340400bps in 2023, then skyrocketed by 496800bps in 2024.
  • OptimizeRx's Operating Margin (Quarter) stood at 3.06% in 2021, then plummeted by -244bps to 4.4% in 2022, then plummeted by -774bps to 38.43% in 2023, then soared by 129bps to 11.25% in 2024, then plummeted by -30bps to 7.86% in 2025.
  • Its Operating Margin was 7.86% in Q3 2025, compared to 10.92% in Q2 2025 and 9.64% in Q1 2025.